Abstract
Tic disorders are stereotypic behaviours,more frequent than once believed, and therefore likely to be encountered by primary care physicians. Tics usually begin in childhood and are the clinical hallmark of Tourette Syndrome (TS), the most common cause of tics. TS is a relatively common neurobehavioural disorder with a spectrum of manifestations that wax and wane during its natural course. The pathophysiology of tics, at molecular and cellular level, is still unknown,whereas structural and functional neuroimaging studies have shown the involvement of the basal ganglia and related cortico–striato–thalamo–cortical circuits, and the dopaminergic neuronal system. Moreover, TS has a strong genetic background. The management of TS is often complicated by the presence of attention–deficit/hyperactivity disorder, obsessivecompulsive disorder, and other behaviour disorders. The correct diagnosis is a fundamental step for a proper management of these disorders, and a multimodal treatment is usually indicated. This approach includes educational and supportive interventions, as well as pharmacological treatments when tics are at their worst.
Similar content being viewed by others
References
Adams JR, Troiano AR, Calne DB (2004) Functional imaging in Tourette’s syndrome. J Neural Transm 111:1495–1506
Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, Minoshima S, Kilbourn MR, Frey KA (2003) Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 61:310–315
Allen AJ (1997) Group streptococcal infections and childhood neuropsychiatric disorder. Curr Opin 267:75
Almeras N, Despres JP, Villeneuve J, Demers MF, Roy MA, Cadrin C, Mottard JP, Bouchard RH (2004) Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. J Clin Psychiatry 65:557–564
Alsobrook JP, Pauls DL (1997) The genetics of Tourette syndrome. Neurol Clin 15:381–893
Amann BL, Pogarell O, Mergl R, Juckel G, Grunze H, Mulert C, Hegerl U (2003) EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects. Hum Psychopharmacol 18:641–646
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Assn 103
Anca MH, Giladi N, Korczyn AD (2004) Ropinirole in Gilles de la Tourette syndrome. Neurology 62:1626–1627
Awaad Y, Michon AM, Minarik S (2005) Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. Mov Disord 20:714–718
Bagheri MM, Kerbeshian J, Burd L (1999) Recognition and management of Tourette’s syndrome and tic disorders. Am Fam Physician 59:2263–2272
Begum M (2005) Clozapine–induced stuttering, facial tics and myoclonic seizures: a case report. Aust N Z J Psychiatry 39:202
Black KJ (2002) Tourette Syndrome and Other Tic Disorders Available from: http://www. eMedicine. com
Black KJ, Mink JW (2000) Response to levodopa challenge in Tourette syndrome. Mov Disord 15:1194–1198
Bonnier C, Nassogne M, Evrard P (1999) Ketanserin Treatment of Tourette’s Syndrome in Children. Am J Psychiatry 156:1122–1123
Bruggeman R, van der Linden C, Buitelaar JK (2001) Risperidone versus pimozide in Tourette’s disorder: a comparative double–blind parallelgroup study. J Clin Psychiatry 62:50–56
Carr JE, Bailey JS (1996) A brief behavior therapy protocol for Tourette syndrome. J Behav Ther Exp Psychiatry 27:33–40
Chang HL, Tu MJ, Wang HS (2004) Tourette’s syndrome: psychopathology in adolescents. Psychiatry Clin Neurosci 58:353–358
Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Arnsten A, Leckman JF, Cohen DJ (1995) Guanfacine treatment of comorbid attentiondeficit hyperactivity disorder and Tourette’s syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 34:1140–1146
Cohen DJ, Jankovic J, Goetz CG (2001) Tourette syndrome. In: Advances in Neurology. Philadelphia, Pa: Lippincott Williams and Wilkins
Crawford FC, Ait–Ghezala G, Morris M, Sutcliffe MJ, Hauser RA, Silver AA, Mullan MJ (2003) Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder. Hum Genet 113:154–161
Cuker A, State MW, King RA, Davis N, Ward DC (2004) Candidate locus for Gilles de la Tourette syndrome/obsessive compulsive disorder/chronic tic disorder at 18q 22.Am J Med Genet 130:37–39
Demirkiran M, Jankovic J (1995) Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 38:571–579
Devor EJ, Magee HJ (1999) Multiple childhood behavioral disorders (Tourette syndrome, multiple tics, ADD, and OCD) presenting in a family with a balanced chromosome translocation (t1; 8)(q21. 1;q22. 1). Psychiatr Genet 9:149–151
Dion Y, Annable L, Sandor P, Chouinard G (2002) Risperidone in the treatment of tourette syndrome: a double–blind, placebo–controlled trial. J Clin Psychopharmacol 22:31–39
Eapen V, Pauls DL, Robertson MM (1993) Evidence for autosomal dominant transmission in Tourette syndrome. Br J Psychiatry 162:593–596
Eichstedt JA, Arnold SL (2001) Childhood– onset obsessive–compulsive disorder: a tic–related subtype of OCD? Clin Psychol Rev 21:137–157
Evidente VG (2000) Is it a tic or Tourette’s? Clues for differentiating simple from more complex tic disorders. Postgraduate Medicine 108:5
Fahn S (1988) Blepharospasm: a form of focal dystonia. Adv Neurol 49:125–133
Fattapposta F, Restuccia R, Colonnese C, Labruna L, Garreffa G, Bianco F (2005) Gilles de la Tourette syndrome and voluntary movement: a functional MRI study. Psychiatry Res 138:269–272
Fountoulakis KN, Iacovides A, St Kaprinis G (2004) Successful treatment of Tourette’s disorder with amisulpride. Ann Pharmacother 38:90
Fredericksen KA, Cutting LE, Kates WR, Mostofsky SH, Singer HS, Cooper KL, et al. (2002) Disproportionate increases of white matter in right frontal lobe in Tourette syndrome. Neurology 58:85–89
Gaffney Gr, Perry PJ, Lund BC, Bever– Stille KA, Arndt S, Kuperman S (2002) Risperidone versus clonidine in the treatment of children and adolescents with Tourette’s syndrome. J Am Acad Child Adolesc Psychiatry 41:330–336
Gaulin BD, Markowitz JS, Caley CF, Nesbitt LA, Dufresne RL (1999) Clozapine– Associated Elevation in Serum Triglycerides. Am J Psychiatry 156:1270–1272
Gazdag G, Barna I, Ivanyi Z, Tolna J (2004) The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy. Ideggyogy Sz 57:385–390
Gerber PE, Lynd LD (1998) Selective serotonin–reuptake inhibitor–induced movement disorders. Ann Pharmacother 32:692–698
Gilbert DL, Batterson JR, Sethuraman G, Sallee FR (2004) Tic reduction with risperidone versus pimozide in a randomized, double–blind, crossover trial. J Am Acad Child Adolesc Psychiatry 43:206–214
Gilbert DL, Dure L, Sethuraman G, Raab D, Lane J, Sallee FR (2003) Tic reduction with pergolide in a randomized controlled trial in children. Neurology 60:606–611
Gilbert DL, Sallee FR, Zhang J, Lipps TD, Wassermann EM (2005) Transcranial Magnetic Stimulation–Evoked Cortical Inhibition: A Consistent Marker of Attention–Deficit/Hyperactivity Disorder Scores in Tourette Syndrome. Biol Psychiatry 57:1597–1600
Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR (2000) Tourette’s syndrome improvement with pergolide in a randomized, double–blind, crossover trial. Neurology 54:1310–1315
Goetz CG, Chmura TA, Lanska DJ (2001) History of tic disorders and Gilles de La Tourette syndrome: Part 5 of the MDS–sponsored history of movement disorders exhibit, Barcelona. Mov Disord 16:346–349
Graybiel AM, Rauch SL (2000) Toward a neurobiology of obsessivecompulsive disorder. Neuron 28:343–347
Hallett JJ, Harling–Berg CJ, Knopf PM, Stopa EG, Kiessling LS (2000) Antistriatal antibodies in Tourette syndrome cause neuronal dysfunction. J Neuroimmunol 111:195–202
Hallett M (2001) Neurophysiology of tics. Adv Neurol 85:237–244
Hamilton CS, Garvey MA, Swedo SE (2001) Therapeutic implications of immunology for tics and obsessivecompulsive disorder. Adv Neurol 85:311–318
Hanna PA, Janjua FN, Contant CF (1999) Bilineal transmission in Tourette syndrome. Neurology 53:813–818
Hanna PA, Jankovic J (2002) Sleep and tic disorders. In: Chokroverty S, Hening Walters A (eds) Sleep and movement disorders. Woburn, Mass Butterworth–Heinemann, pp 181–189
Hoekstra PJ, Anderson GM, Limburgc PC, Korfd J, Kallenbergc CGM, Minderaa RB (2004) Neurobiology and neuroimmunology of Tourette’s syndrome: an update
Hornsey H, Banerjee S, Zeitlin H, Robertson M (2001) The prevalence of Tourette syndrome in 13–14–year–olds in mainstream schools. J Child Psycol Psychiatry 42:1035–1039
Horrigan JP, Barnhill LJ (1995) Guanfacine for treatment of attentiondeficit hyperactivity disorder in boys. J Child Adolesc Psychopharmacol 5:215–223
Hunt RD, Arnsten AFT, Asbell MD (1995) An open trial of guanfacine in the treatment of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34:50–54
Hyde TM, Aaronson BA, Randolph C, Rickler KC, Weinberger DR (1992) Relationship of birth weight to the phenotypic expression of Gilles de la Tourette’s syndrome in monozygotic twins. Neurology 42:652–658
Jankovic J (1997) Tourette syndrome: phenomenology and classification of tics. Neurol Clin 15:267–275
Jankovic J (2001) Tourette’s syndrome. N Engl J Med 345:1184–1192
Jankovic J (2001) Differential diagnosis and etiology of tics. Adv Neurol 85:15–29
Jimenez–Jimenez FJ, Garcia–Ruiz PJ (2001) Pharmacological options for treatment of Tourette’s disorder. Drugs 61:2207–2220
Kates WR, Frederikse M, Mostofsky SH, Folley BS, Cooper K, Mazur–Hopkins P, Kofman O, Singer HS, Denckla MB, Pearlson GD, Kaufmann WE (2002) MRI parcellation of the frontal lobe in boys with attention deficit hyperactivity disorder or Tourette syndrome. Psychiatry Res 116:63–81
Kiessling LS, Marcotte AC, Culpepper L (1993) Antineuronal antibodies in movement disorders. Pediatrics 92:39–43
King RA, Scahill L (2001) Emotional and behavioral difficulties associated with Tourette syndrome. Adv Neurol 85:79–88
Kofoed L, Tadepalli G, Oesterheld JR, Awadallah S, Shapiro R (1999) Case series: clonidine has no systematic effects on PR or QTc intervals in children. J Am Acad Child Adolesc Psychiatry 38:1193–1196
Kossoff EH, Singer HS (2001) Tourette syndrome: clinical characteristics and current management strategies. Paediatr Drugs 3:355–363
Kumar R, Lang AE (1997) Tourette syndrome. Secondary tic disorders. Neurol Clin 15:309–331
Kurlan K, Lichter D, Hewitt D (1989) Sensory tics in Tourette’s Syndrome. Neurology 39:731–734
Kurlan R, Como PG, Miller B (2002) The behavioural spectrum of tic disorders: a community–based study. Neurology 59:414–420
Kurlan R (1997) Tourette syndrome. Treatment of tics. Neurol Clin 15:403–409
Kurlan R (1998) Tourette’s syndrome and ‘PANDAS’:Will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Neurology 50:1530–1534
Kwak C, Dat VK, Jankovic J (2003) Premonitory sensory phenomenon in Tourette’s syndrome. Mov Disord 18:1530–1533
Kwak C, Vuong KD, Jankovic J (2003) Migraine headache in patients with Tourette syndrome. Arch Neurol 60:1595–1598
Kwak CH, Hanna PA, Jankovic J (2000) Botulinum toxin in the treatment of tics. Arch Neurol 57:1190–1193
Lang AE (1991) Patient perception of tics and other movement disorders. Neurology 41:223–228
Lang AE (2001) Update on the treatment of tics. Adv Neurol 85:355–362
Lebovitz HE (2003) Metabolic consequences of atypical antipsychotic drugs. Psychiatr Q Fall 74:277–290
Leckman JF, Cohen DJ (1988) Descriptive and diagnostic classification of tic disorders. In: Cohen DJ, Bruun RD, Leckman JF (eds) Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment. New York, NY: John Wiley and Sons, pp 3–21
Leckman JF, Cohen DJ (1999) Tourette’s syndrome–Tics, Obsessions, Compulsions: Developmental Psychopathology and Clinical Care. New York: John Wiley and Sons
Leckman JF, Dolnansky ES, Hardin MT, Clubb M, Walkup JT, Stevenson J, et al. (1990) Perinatal factors in the expression of Tourette’s syndrome: an exploratory study. J Am Acad Child Adolesc Psychiatry 29:220–226
Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ (1991) Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 48:324–328
Leckman JF, Katsovich L, Kawikova I, Lin H, Zhang H, Kronig H, Morshed S, Parveen S, Grantz H, Lombroso PJ, King RA (2005) Increased serum levels of interleukin–12 and tumor necrosis factor–alpha in Tourette’s syndrome. Biol Psychiatry 57:667–673
Leckman JF, Peterson BDS, Anderson GM, Arnsten ATF, Pauls DL, Cohen DJ (1997) Pathogenesis of Tourette’s syndrome. J Child Psychol Psychiatry 38:119–142
Leckman JF, Peterson BS, King RA (2001) Phenomenology of tics and natural history of tic disorders. Adv Neurol 85:1–14
Leckman JF, Peterson BS, Pauls DL, Cohen DJ (1997) Tic disorders. Psychiatr Clin North Am 20:839–861
Leckman JF, Riddle MA (2000) Tourette's syndrome: when habitforming systems form habits of their own? Neuron 28:349–354
Leckman JF, Walker DE, Cohen DJ (1993) Premonitory urges in Tourette's syndrome. Am J Psychiatry 150:98–102
Lesperance P, Djerroud N, Diaz Anzaldua A, Rouleau GA, Chouinard S, Richer F;Montreal Tourette Study Group (2004) Restless legs in Tourette syndrome. Mov Disord 19:1084–1087
Marcus D, Kurlan R (2001) Tics and its disorders. Neurol Clin 19:735–758
Marras C, Andrews D, Sime E, Lang AE (2001) Botulinum toxin for simple motor tics: a randomized, doubleblind, controlled clinical trial. Neurology 56:605–610
Merette C, Brassard A, Potvin A, Bouvier H, Rousseau F, Emond C, et al. (2000) Significant linkage for Tourette syndrome in a large French Canadian family. Am J Hum Genet 67:1008–1013
Mink JW (2003) The basal ganglia and involuntary movements. Arch Neurol 60:1365–1368
Mink JW (1996) The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 50:381–425
Mink JW (2001) Neurobiology of basal ganglia circuits in Tourette syndrome: faulty inhibition of unwanted motor patterns? Adv Neurol 85:113–122
Morshed SA, Parveen S, Leckman JF (2001) Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette’s syndrome, Sydenham’s chorea, and autoimmune disorders. Biol Psychiatry 50:566–577
Mukaddes NM, Abali O (2003) Quetiapine treatment of children and adolescents with Tourette’s disorder. J Child Adolesc Psychopharmacol 13:295–299
Mullen N, Riedel M, Straube A, Gunther W, Wilske B (2000) Increased anti–streptococcal antibodies in patients with Tourette's syndrome. Psychiatry Res 94:43–49
Muller N (2004) Anti–inflammatory therapy with a COX–2 inhibitor in Tourette's syndrome. Inflammopharmacology 12:271–275
Muller N, Riedel M, Blendinger C, Oberle K, Jacobs E, Abele–Horn M (2004) Mycoplasma pneumoniae infection and Tourette's syndrome. Psychiatry Res 129:119–125
Muller–Vahl KR (2002) The treatment of Tourette’s syndrome: current opinions. Expert Opin Pharmacother 3:899–914
Muller–Vahl KR (2003) Cannabinoids reduce symptoms of Tourette's syndrome. Expert Opin Pharmacother 4:1717–1725
Muller–Vahl KR, Kolbe H, Schneider U (1999) Cannabis in movement disorders. Forsch Komplementarmed 6:23–27
Muller–Vahl KR, Meyer GJ, Knapp WH, Emrich HM, Gielow P, Brucke T, Berding G (2005) Serotonin transporter binding in Tourette Syndrome. Neurosci Lett (Epub ahead of print)
Muller–Vahl KR, Prevedel H, Theloe K, Kolbe H, Emrich HM, Schneider U (2003) Treatment of Tourette syndrome with delta–9–tetrahydrocannabinol (delta 9–THC): no influence on neuropsychological performance. Neuropsychopharmacology 28:384–388
Murphy TK, Bengtson MA, Soto O, Edge PJ, Sajid MW, Shapira N, Yang M (2005) Case series on the use of aripiprazole for Tourette syndrome. Int J Neuropsychopharmacol 28:1–2
Murphy TK, Goodman WK, Fudge MW (1997) B lymphocyte antigen D8/17: a peripheral marker for childhood– onset obsessive–compulsive disorder and Tourette's syndrome? Am J Psychiatry 154:402–407
Niederhofer H, Staffen W, Mair A (2003) A placebo–controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. J Psychopharmacol 17:113–119
Nordstrom EJ, Burton FH (2002) A transgenic model of comorbid Tourette's syndrome and obsessivecompulsive disorder circuitry. Mol Psychiatry 7:524
Olson S (2004) Neurobiology. Making sense of Tourette's. Science 305:1390–1392
Onofrj M, Paci G, D'Andrea M, Toma L (2000) Olanzapine in severe Gilles de la Tourette syndrome: a 52–week double–blind cross–over study vs. low–dose pimozide. J Neurol 247:443–446
Orth M, Amann B, Robertson MM, Rothwell JC (2005) Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine. Brain 128:292–1300
Parraga HC, Parraga MI, Woodward RL, Fenning PA (2003) Quetiapine treatment of children with Tourette's syndrome: report of two cases. J Am Acad Child Adolesc Psychiatry 42:623–624
Paschou P, Feng Y, Pakstis AJ, Speed WC, DeMille MM, Kidd JR, Jaghori B, Kurlan R, Pauls DL, Sandor P, Barr CL, Kidd KK (2004) Indications of linkage and association of Gilles de la Tourette syndrome in two independent family samples: 17q25 is a putative susceptibility region. Am J Hum Genet 75:545–560
Pauls DL (2001) Update on the genetics of Tourette syndrome. Adv Neurol 85:281–293
Pauls DL (2003) An update on the genetics of Gilles de la Tourette syndrome. J Psychosom Res 55:7–12
Perlmutter SJ, Garvey MA, Castellanos X, Mittleman BB, Giedd J, Rapoport JL, Swedo SE (1998) A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Am J Psychiatry 155:1592–1598
Perry P, Gaffney G Pediatric Psychopharmacology: Tourette's Syndrome. Clinical Psychopharmacology Seminar 1996 Peer Review. Available from: http://www. vh. org/Providers/ Conferences/CPS/42. html 4
Peterson AL, Azrin NH (1992) An evaluation of behavioral treatments for Tourette syndrome. Behav Res Ther 30:167–174
Peterson BS, Thomas P, Kane MJ, Scahill L, Zhang H, Bronen R, King RA, Leckman JF, Staib L (2003) Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 60:415–424
Plessen KJ, Wentzel–Larsen T, Hugdahl K, Feineigle P, Klein J, Staib LH, Leckman JF, Bansal R, Peterson BS (2004) Altered interhemispheric connectivity in individuals with Tourette's disorder. Am J Psychiatry 161:2028–2037
Pogarell O, Juckel G, Mulert C, Amann B, Möller HJ, Heger U (2004) EEG Abnormalities Under Treatment with Atypical Antipsychotics: Effects of Olanzapine and Amisulpride as Compared to Haloperidol. Pharmacopsychiatry 37:304–305
Porta M, Maggioni G, Ottaviani F, Schindler A (2004) Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A Neurol Sci 24:420–423
Posey DJ, Puntney JI, Sasher TM, Kem DL, McDougle CJ (2004) Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases. J Child Adolesc Psychopharmacol 14:233–241
Poyurovsky M, Bergman Y, Shoshani D, Schneidman M, Weizman A (1998) Emergence of obsessive–compulsive symptoms and tics during clozapine withdrawal. Clin Neuropharmacol 21:97–100
Raffaele R, Vecchio I, Alvano A, Proto G, Nicoletti G, Rampello L (2004) Blink reflex abnormalities in Tourette sindrome. Clin Neurophysiol 115:320–324
Rampello L, Nicoletti G, Vecchio I (1995) Clinical and evolutive aspects of Tourette's syndrome. J Neurol 242:88
Rampello L, Vecchio I, Furnari P (2000) Tourette's sindrome: phenotipic and aetiopathogenetic spectrum. Mov Disord 15:248
Robertson MM (2000) Tourette syndrome, associated conditions and the complexities of treatment. Brain 123:425–462
Rothenberger A, Kostanecka T, Kinkelbur J, Cohrs S, Woerner W, Hajak G (2001) Sleep and Tourette syndrome. In: Cohen DJ, Jankovic J, Goetz CG (eds) Tourette syndrome. Vol 85 of Advances in neurology. Philadelphia: Lippincott Williams and Wilkins, pp 245–259
Ruth U, Mayer–Rosa J, Schlamp D, Freisleder FJ (2000) Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine. Z Kinder Jugendpsychiatr Psychother 28:105–108
Sallee FR, Kurlan R, Goetz CG, Singer H, Scahill L, Law G, Dittman VM, Chappell PB (2000) Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 39:292–299
Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G (1997) Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry 154:1057–1062
Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, Arnsten AF, Cohen DJ, Leckman JF (2001) A Placebo–Controlled Study of Guanfacine in the Treatment of Children With Tic Disorders and Attention Deficit Hyperactivity Disorder. Am J Psychiatry 158:1067–1074
Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS (2003) A placebo–controlled trial of risperidone in Tourette syndrome. Neurology 60:1130–1135
T L, Tanner C, Dure L (2001) The epidemiology of tics and Tourette syndrome in children and adolescents. Adv Neurol 85:261–271
Serrien DJ, Orth M, Evans AH, Lees AJ, Brown P (2005) Motor inhibition in patients with Gilles de la Tourette syndrome: functional activation patterns as revealed by EEG coherence. Brain 128:116–125
Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, Phillips RA (1989) Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 46:722–730
Silay YS, Jankovic J (2005) Emerging drugs in Tourette syndrome. Expert Opin Emerg Drugs 10:365–380
Silver AA, Shytle RD, Philipp MK (2001) Transdermal nicotine and haloperidol in Tourette's disorder: a double–blind placebo–contolled study. J Clin Psychiatry 62:707–714
Simonic I, Nyholt DR, Gericke, GS, Gordon D, Matsumoto N, Ledbetter DH, Ott J, Weber JL (2001) Further evidence for linkage of Gilles de la Tourette syndrome (GTS) susceptibility loci on chromosomes 2p11, 8q22, and 11q23–24 in South African Afrikaners. Am J Med Genet 105:163–167
Singer HS (1995) Neurobiology of Tourette syndrome Biol Psychiatry 37:629
Singer HS (2000) Current issues in Tourette Syndrome. Mov Disord 15:1051–1063
Singer HS (2005) Tourette's syndrome: from behaviour to biology. Lancet Neurol 4:149–159
Singer HS, Giuliano JD, Hansen BH, Hallett JJ, Laurino JP, Benson M, Kiessling LS (1998) Antibodies against human putamen in children with Tourette syndrome. Neurology 50:1618–1624
Singer HS, Giuliano JD, Hansen BH, et al. (1999) Antibodies against a neuron–like (HTB10 neuroblastoma) cell in children with Tourette syndrome. Biol Psychiatry 46:775–780
Singer HS, Krumholz A, Giuliano J, Kiessling LS (1997) Antiphospholipid antibodies: an epiphenomenon in Tourette syndrome. Mov Disord 12:738–742
Smith JL, Johnstone SJ, Barry RJ (2004) Inhibitory processing during the Go/NoGo task: an ERP analysis of children with attention–deficit/hyperactivity disorder. Clin Neurophysiol 115:1320–1331
Smith SJ, Lees AJ (1989) Abnormalities of the blink reflex in Gilles de la Tourette syndrome. J Neurol Neurosurgery Psychiatry 52:895–898
State MW, Greally JM, Cuker A, Bowers PN, Henegariu O, Morgan TM, et al. (2003) Epigenetic abnormalities associated with a chromosome 18(q21–q22) inversion and a Gilles de la Tourette syndrome phenotype. Proc Natl Acad Sci USA 100:4684–4689
Stein DJ (2002) Obessive–compulsive disorder. Lancet 360:397–405
Stephens RJ, Bassel C, Sandor P (2004) Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome–a pilot study. J Child Adolesc Psychopharmacol 14:255–266
Stern JS, Burza S, Robertson MM (2005) Gilles de la Tourette's syndrome and its impact in the UK. Postgrad Med J 81:12–19
Tatlipinar S, Iener EC, Ilhan B (2001) Ophtalmic manifestations of Gilles de la Tourette syndrome. Eur Ophtalmol 11:223–226
Temel Y, Visser–Vandewalle V (2004) Surgery in Tourette syndrome. Mov Disord 19:3–14
The Tourette Syndrome Association International Consortium for Genetics (1999) A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. Am J Hum Genet 65:1428–1436
The Tourette Syndrome Classification Study Group (1993) Definitions and classification of tic disorders. Arch Neurol 50:1013–1016
Tolchard B (1995) Treatment of Gilles de la Tourette syndrome using behavioural psychotherapy: a single case example. J Psychiatr Ment Health Nurs 2:233–236
Toren P, Toren A, Weizman A, Mozes T, Eldar S, Magor A, Mandel M, Rechavi G, Many A, Mester R (1994) Tourette's disorder: is there an association with the antiphospholipid syndrome? Biol Psychiatry 35:495–498
Toren P, Weizman A, Ratner S, Cohen D, Laor N (2005) Ondansetron treatment in Tourette's disorder: a 3–week, randomized, double–blind, placebocontrolled study. J Clin Psychiatry 66:499–503
Tourette's Syndrome Study Group (2002) Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 58:527–536
Vandewalle V, van der Linden C, Groenewegen HJ (1999) Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet 353:724
Verdellen CW, Keijsers GP, Cath DC, Hoogduin CA (2004) Exposure with response prevention versus habit reversal in Tourettes's syndrome: a controlled study. Behav Res Ther 42:501–511
Verkerk AJ, Mathews CA, Joosse M, Eussen BH, Heutink P, Oostra BA, and the Tourette Syndrome Association International Consortium for Genetics (2003) CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 82:1–9
Voelker R (2004) Scientists use neuroimaging, genetic studies to probe biology of tourette syndrome. JAMA 292:909–911
Walkup JT, LaBuda MC, Singer HS, Brown J, Riddle MA, Hurko O (1996) Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance. Am J Hum Genet 59:684–693
Wilhelm S, Deckersbach T, Coffey BJ, Bohne A, Peterson AL, Baer L (2003) Habit Reversal Versus Supportive Psychotherapy for Tourette's Disorder: A Randomized Controlled Trial. Am J Psychiatry 160:1175–1177
Wolf SS, Jones DW, Knable MB, Gorey JG, Lee KS, Hyde TM, et al. (1996) Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 273:1225–1227
Woods DW, Twohig MP, Flessner CA, Roloff TJ (2003) Treatment of vocal tics in children with Tourette syndrome: investigating the efficacy of habit reversal. J Appl Behav Anal 36:109–112
Zhang H, Leckman JF, Pauls DL, Tsai CP, Kidd KK, Campos MR (2002) Genome wide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. Am J Hum Genet 70:896–904
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rampello, L., Alvano, A., Battaglia, G. et al. Tic disorders: from pathophysiology to treatment. J Neurol 253, 1–15 (2006). https://doi.org/10.1007/s00415-005-0008-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0008-8